118 related articles for article (PubMed ID: 36533702)
61. Age cut-off for reporting endometrial cells on a Papanicolaou test: 50 years may be more appropriate than 45 years.
Weiss VL; Cate F; Bloom L; Fadare O; Coogan AC; Desouki MM
Cytopathology; 2016 Aug; 27(4):242-8. PubMed ID: 26689647
[TBL] [Abstract][Full Text] [Related]
62. Combining copy number, methylation markers, and mutations as a panel for endometrial cancer detection via intravaginal tampon collection.
Sangtani A; Wang C; Weaver A; Hoppman NL; Kerr SE; Abyzov A; Shridhar V; Staub J; Kocher JA; Voss JS; Podratz KC; Wentzensen N; Kisiel JB; Sherman ME; Bakkum-Gamez JN
Gynecol Oncol; 2020 Feb; 156(2):387-392. PubMed ID: 31787246
[TBL] [Abstract][Full Text] [Related]
63. Developing and validating ultrasound-based radiomics models for predicting high-risk endometrial cancer.
Moro F; Albanese M; Boldrini L; Chiappa V; Lenkowicz J; Bertolina F; Mascilini F; Moroni R; Gambacorta MA; Raspagliesi F; Scambia G; Testa AC; Fanfani F
Ultrasound Obstet Gynecol; 2022 Aug; 60(2):256-268. PubMed ID: 34714568
[TBL] [Abstract][Full Text] [Related]
64. Development and Validation of a Five-immune Gene Pair Signature in Endometrial Carcinoma.
Li N; Yu K; Lin Z; Zeng D
Comb Chem High Throughput Screen; 2021; 24(2):233-245. PubMed ID: 32729416
[TBL] [Abstract][Full Text] [Related]
65. Diagnostic value of carbohydrate antigen 72-4 combined with carbohydrate antigen 15.3 in ovarian cancer, cervical cancer and endometrial cancer.
Li M; Men X; Zhang X
J BUON; 2020; 25(4):1918-1927. PubMed ID: 33099933
[TBL] [Abstract][Full Text] [Related]
66. Establishment and validation of a prognostic nomogram based on a novel five-DNA methylation signature for survival in endometrial cancer patients.
Li X; Yin F; Fan Y; Cheng Y; Dong Y; Zhou J; Wang Z; Li X; Wang J
Cancer Med; 2021 Jan; 10(2):693-708. PubMed ID: 33350104
[TBL] [Abstract][Full Text] [Related]
67. A pilot study of HPV DNA and cytology testing in 50,159 women in the routine Mexican Social Security Program.
Lazcano-Ponce E; Lörincz AT; Salmerón J; Fernández I; Cruz A; Hernández P; Mejia I; Hernández-Avila M
Cancer Causes Control; 2010 Oct; 21(10):1693-700. PubMed ID: 20617376
[TBL] [Abstract][Full Text] [Related]
68. Can Genomic Amplification of Human Telomerase Gene and C-MYC in Liquid-Based Cytological Specimens Be Used as a Method for Opportunistic Cervical Cancer Screening?
Gao K; Eurasian M; Zhang J; Wei Y; Zheng Q; Ye H; Li L
Gynecol Obstet Invest; 2015; 80(3):153-63. PubMed ID: 25832290
[TBL] [Abstract][Full Text] [Related]
69. Potential of blood-based biomarker approaches in endometrium and breast cancer: a case-control comparison study.
Schuhn A; Tobar TW; Gahlawat AW; Hauke J; Baumann L; Okun JG; Nees J
Arch Gynecol Obstet; 2022 Nov; 306(5):1623-1632. PubMed ID: 35284957
[TBL] [Abstract][Full Text] [Related]
70. Discovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2/3.
Boers A; Wang R; van Leeuwen RW; Klip HG; de Bock GH; Hollema H; van Criekinge W; de Meyer T; Denil S; van der Zee AGJ; Schuuring E; Wisman GBA
Clin Epigenetics; 2016; 8():29. PubMed ID: 26962367
[TBL] [Abstract][Full Text] [Related]
71. Controversies on Transvaginal Ultrasound Screening for Endometrial Cancer in Asymptomatic Postmenopausal Women.
Tsikouras P; Bacha M; Zervoudis S; Koukouli Z; Iatrakis G; Galazios G; Maroulis G; Virtej I; Onofriescu M
Rev Med Chir Soc Med Nat Iasi; 2016; 120(4):855-60. PubMed ID: 30141611
[TBL] [Abstract][Full Text] [Related]
72. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.
Leinonen M; Nieminen P; Kotaniemi-Talonen L; Malila N; Tarkkanen J; Laurila P; Anttila A
J Natl Cancer Inst; 2009 Dec; 101(23):1612-23. PubMed ID: 19903804
[TBL] [Abstract][Full Text] [Related]
73. Clinicopathologic characteristics and outcomes of endometrial Cancer patients with mismatch repair deficiency in the era of universal Lynch syndrome screening.
Carr C; Son J; Yao M; Priyadarshini A; Marquard J; Vargas R; Michener C; AlHilli MM
Gynecol Oncol; 2020 Dec; 159(3):712-720. PubMed ID: 33046272
[TBL] [Abstract][Full Text] [Related]
74. Methylation analysis of the FAM19A4 gene in cervical scrapes is highly efficient in detecting cervical carcinomas and advanced CIN2/3 lesions.
De Strooper LM; Meijer CJ; Berkhof J; Hesselink AT; Snijders PJ; Steenbergen RD; Heideman DA
Cancer Prev Res (Phila); 2014 Dec; 7(12):1251-7. PubMed ID: 25281488
[TBL] [Abstract][Full Text] [Related]
75. Deep learning based cervical screening by the cross-modal integration of colposcopy, cytology, and HPV test.
Fu L; Xia W; Shi W; Cao GX; Ruan YT; Zhao XY; Liu M; Niu SM; Li F; Gao X
Int J Med Inform; 2022 Mar; 159():104675. PubMed ID: 34979436
[TBL] [Abstract][Full Text] [Related]
76. Plasma-derived exosomal miR-15a-5p as a promising diagnostic biomarker for early detection of endometrial carcinoma.
Zhou L; Wang W; Wang F; Yang S; Hu J; Lu B; Pan Z; Ma Y; Zheng M; Zhou L; Lei S; Song P; Liu P; Lu W; Lu Y
Mol Cancer; 2021 Mar; 20(1):57. PubMed ID: 33781255
[TBL] [Abstract][Full Text] [Related]
77. Point-of-care HPV DNA testing of self-collected specimens and same-day thermal ablation for the early detection and treatment of cervical pre-cancer in women in Papua New Guinea: a prospective, single-arm intervention trial (HPV-STAT).
Vallely AJB; Saville M; Badman SG; Gabuzzi J; Bolnga J; Mola GDL; Kuk J; Wai M; Munnull G; Garland SM; Brotherton JML; Kelly-Hanku A; Morgan C; Toliman PJ; Kombati Z; Kariwiga G; Babona D; Tan G; Simms KT; Cornall AM; Tabrizi SN; Wand H; Guy R; Canfell K; Kaldor JM
Lancet Glob Health; 2022 Sep; 10(9):e1336-e1346. PubMed ID: 35878625
[TBL] [Abstract][Full Text] [Related]
78. High-Grade Squamous Intraepithelial Lesion Cytology With Negative High-Risk Human Papillomavirus Tests Rarely Diagnoses Endometrial Cancer.
Pretorius RG; Peterson P
J Low Genit Tract Dis; 2015 Jul; 19(3):200-2. PubMed ID: 25148229
[TBL] [Abstract][Full Text] [Related]
79. Comparison of screening strategies for Lynch syndrome in patients with newly diagnosed endometrial cancer: a prospective cohort study in China.
Chao X; Li L; Wu M; Ma S; Tan X; Zhong S; Bi Y; Lang J
Cancer Commun (Lond); 2019 Jul; 39(1):42. PubMed ID: 31307542
[TBL] [Abstract][Full Text] [Related]
80. Cervical cancer risk in HPV-positive women after a negative FAM19A4/mir124-2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow-up.
De Strooper LMA; Berkhof J; Steenbergen RDM; Lissenberg-Witte BI; Snijders PJF; Meijer CJLM; Heideman DAM
Int J Cancer; 2018 Sep; 143(6):1541-1548. PubMed ID: 29663363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
